Posted on December 21, 2021
![]()
Tennessee Oncology has received re-certification by the QOPI® Certification Program, LLC, a wholly owned subsidiary of the Association for Clinical Oncology (the Association) and an affiliate of the American Society of Clinical Oncology (the Society). The QOPI® Certification Program builds on the Society’s Quality Oncology Practice Initiative (QOPI®), providing a three-year certification for outpatient hematology-oncology […]
Read More
Posted on December 16, 2021
Provision CARES Proton Therapy Nashville has been accredited by the American Society for Radiation Oncology (ASTRO) through APEx – Accreditation Program for Excellence®. This achievement means cancer patients in Middle Tennessee not only have access to one of the world’s most advanced cancer treatments, but can also rest assured knowing their care will be of […]
Read More
Posted on December 10, 2021
![]()
H3 Biomedicine Inc. (H3), a U.S.-based precision medicine research & development subsidiary of Eisai Co., Ltd., today announced the presentation of two posters at the 2021 San Antonio Breast Cancer Symposium (SABCS) being held in a hybrid format on December 7- 10, 2021. The presentations include interim investigational data from H3’s ongoing clinical development program, […]
Read More
Posted on December 3, 2021
For Americans with cancer, building back better from the pandemic should improve local care – not destroy it, causing higher costs and less access to community cancer doctors. But, with Congress on the verge of rushing through massive changes to Medicare in the Build Back Better Act, an independent analysis shows that payments to cancer […]
Read More
